Long-term survival in prostate squamous cell carcinoma after chemo-radiation
Author Information
Author(s): Fernando Munoz, Franco Pierfrancesco, Patrizia Ciammella, Mario Clerico, Mauro Giudici, Andrea Riccardo Filippi, Umberto Ricardi
Primary Institution: University of Torino, Ospedale S. Giovanni Battista, Torino, Italy
Hypothesis
Can combined chemo-radiation improve survival in patients with pure squamous cell carcinoma of the prostate?
Conclusion
The study shows that combined chemo-radiation can lead to prolonged disease control and survival in patients with pure squamous cell carcinoma of the prostate.
Supporting Evidence
- The patient was treated with a combination of chemotherapy and radiation.
- He remained free of disease for 5 years after treatment.
Takeaway
Doctors treated a man with a rare type of prostate cancer using both chemotherapy and radiation, and he lived without cancer for 5 years.
Methodology
The patient received 3 courses of cisplatin and continuous infusion of 5-fluorouracil followed by radiotherapy.
Limitations
The study is based on a single case report, limiting generalizability.
Participant Demographics
76-year-old male patient.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website